Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06876857 · ClinicalTrials.gov registry record
University of Central Florida CereBank
A clinical trial of Brain Diseases and Brain Injury, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT06876857 is a study of Brain Diseases and Brain Injury that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 50,000 participants, above the 1,852-participant average among 12 other Brain Diseases trials with a reported enrollment target (2600% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06876857, a study of Brain Diseases and Brain Injury, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.
Conditions Studied
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2025-02-25 |
| Est. Completion | 2075-02-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06876857
The ClinicalTrials.gov registry entry for NCT06876857 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,852-participant average among 12 other Brain Diseases trials with a reported enrollment target (2600% higher). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Brain Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06876857 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06876857 about?
NCT06876857 is a clinical study titled "University of Central Florida CereBank". Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have ...
What is the current status of trial NCT06876857?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2025-02-25. Estimated completion is 2075-02-25.
What conditions does trial NCT06876857 study?
This clinical trial studies the following conditions: Brain Diseases, Brain Injury, Biospecimen Donation.
Who is sponsoring clinical trial NCT06876857?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06876857 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RECRUITING · Phase 1
-
Amygdala Memory Enhancement
RECRUITING · NA
-
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
RECRUITING · NA
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
ACTIVE NOT RECRUITING · NA
-
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.